#AIDS2022: Roll-out CAB-LA faster
On the eve of the 24th International Aids conference, the World Health Organisation (WHO) urged countries to use long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV. WHO said CAB-LA is a safe and highly effective prevention option for…